573 related articles for article (PubMed ID: 25141897)
1. Personalized pharmacogenomics profiling using whole-genome sequencing.
Mizzi C; Peters B; Mitropoulou C; Mitropoulos K; Katsila T; Agarwal MR; van Schaik RH; Drmanac R; Borg J; Patrinos GP
Pharmacogenomics; 2014 Jun; 15(9):1223-34. PubMed ID: 25141897
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide association study: a useful tool to identify common genetic variants associated with drug toxicity and efficacy in cancer pharmacogenomics.
Low SK; Takahashi A; Mushiroda T; Kubo M
Clin Cancer Res; 2014 May; 20(10):2541-52. PubMed ID: 24831277
[TBL] [Abstract][Full Text] [Related]
3. [Translational approach for pharmacogenomics and personalized medicine].
Zhang W; Zhou HH
Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
[TBL] [Abstract][Full Text] [Related]
4. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
Albertini L; Siest G; Jeannesson E; Visvikis-Siest S
Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430
[TBL] [Abstract][Full Text] [Related]
5. One size fits one: pharmacogenetics in gastroenterology.
Porayette P; Flockhart D; Gupta SK
Clin Gastroenterol Hepatol; 2014 Apr; 12(4):565-70. PubMed ID: 24486737
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics: historical perspective and current status.
Charlab R; Zhang L
Methods Mol Biol; 2013; 1015():3-22. PubMed ID: 23824846
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomics--10 years of progress: a cardiovascular perspective.
Winkelmann BR; Herrington D
Pharmacogenomics; 2010 May; 11(5):613-6. PubMed ID: 20415546
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics of adverse drug reactions: practical applications and perspectives.
Becquemont L
Pharmacogenomics; 2009 Jun; 10(6):961-9. PubMed ID: 19530963
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of second-generation antipsychotics.
Brennan MD
Pharmacogenomics; 2014 Apr; 15(6):869-84. PubMed ID: 24897292
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics of adverse drug reactions: implementing personalized medicine.
Wei CY; Lee MT; Chen YT
Hum Mol Genet; 2012 Oct; 21(R1):R58-65. PubMed ID: 22907657
[TBL] [Abstract][Full Text] [Related]
11. Personalized medicine - the promised land: are we there yet?
Li C
Clin Genet; 2011 May; 79(5):403-12. PubMed ID: 21204795
[TBL] [Abstract][Full Text] [Related]
12. [From pharmacogenetics to pharmacogenomics: the start of a new era of personalized medicine in nephrology].
Zaza G; Granata S; Mangino M; Grandaliano G; Schena FP
G Ital Nefrol; 2010; 27(4):353-66. PubMed ID: 20672232
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetic content of commercial genome-wide genotyping arrays.
Lemieux Perreault LP; Zaïd N; Cameron M; Mongrain I; Dubé MP
Pharmacogenomics; 2018 Oct; 19(15):1159-1167. PubMed ID: 30272537
[TBL] [Abstract][Full Text] [Related]
14. [Challenge in genome-wide association study for establishment of personalized medicine: focusing on the pharmacogenomics of warfarin and carbamazepine].
Mushiroda T
Rinsho Byori; 2013 May; 61(5):422-7. PubMed ID: 23947182
[TBL] [Abstract][Full Text] [Related]
15. Whole-genome sequencing in pharmacogenetics.
Urban TJ
Pharmacogenomics; 2013 Mar; 14(4):345-8. PubMed ID: 23438878
[No Abstract] [Full Text] [Related]
16. Clinical association between pharmacogenomics and adverse drug reactions.
Zhou ZW; Chen XW; Sneed KB; Yang YX; Zhang X; He ZX; Chow K; Yang T; Duan W; Zhou SF
Drugs; 2015 Apr; 75(6):589-631. PubMed ID: 25895462
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics of the response to IFN-beta in multiple sclerosis: ramifications from the first genome-wide screen.
Vandenbroeck K; Matute C
Pharmacogenomics; 2008 May; 9(5):639-45. PubMed ID: 18466107
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers and personalized therapy in chronic kidney diseases.
Schena FP
Expert Opin Investig Drugs; 2014 Aug; 23(8):1051-4. PubMed ID: 24857812
[TBL] [Abstract][Full Text] [Related]
19. Next-generation sequencing of pharmacogenes: a critical analysis focusing on schizophrenia treatment.
Drögemöller BI; Wright GE; Niehaus DJ; Emsley R; Warnich L
Pharmacogenet Genomics; 2013 Dec; 23(12):666-74. PubMed ID: 24141736
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacogenomics].
Nakatani K; Nobori T
Rinsho Byori; 2013 Nov; 61(11):1018-25. PubMed ID: 24450107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
